Geneticist and James McGill professor of pharmacology and therapeutics

Moshe Szyf is a geneticist and James McGill professor of pharmacology and therapeutics at the McGill University, where he also holds a GlaxoSmithKline-CIHR chair in pharmacology. He is one of the pioneers of epigenetics.

As of January 2017, Moshe Szyf published 262 papers in peer-reviewed journals, almost all on epigenetics.​

Moshe Szyf has proposed three decades ago that DNA methylation is a prime therapeutic target in cancer and other diseases and has postulated and provided the first set of evidence that the “social environment” early in life can alter DNA methylation launching the emerging field of “social epigenetics”.

 

  What is epigenetic and why knowing it will change your life? 
David Laroche is interviewing the Doctor Moshe Szyf. 
     

Moshe Szyf's talk, given at a TED event in Bratislava. 

Epigenetics - our bodies' way to change the destiny written in our DNA.